Shares of Evotec SE (OTCMKTS:EVTCY – Get Free Report) crossed below its 50 day moving average during trading on Tuesday . The stock has a 50 day moving average of $2.91 and traded as low as $2.75. Evotec shares last traded at $2.80, with a volume of 55,550 shares traded.
Evotec Trading Up 2.2%
The firm has a market cap of $924.62 million, a P/E ratio of 6.83 and a beta of 0.98. The business’s 50 day moving average is $2.91 and its 200-day moving average is $3.06. The company has a quick ratio of 2.50, a current ratio of 2.57 and a debt-to-equity ratio of 0.53.
Evotec Company Profile
Evotec SE is a Germany-based biotechnology company specializing in drug discovery alliance and development partnerships. Headquartered in Hamburg, the company collaborates with pharmaceutical and biotechnology firms to deliver integrated solutions across the drug discovery and development continuum. Its offerings span from target identification and validation to lead optimization, preclinical development and manufacturing support.
The company’s platform combines expertise in assay development, high-throughput screening, medicinal chemistry, in vivo pharmacology and safety assessment.
Featured Stories
- Five stocks we like better than Evotec
- NextEra’s Dominion Deal Could Put It at the Center of the AI Power Race
- Amazon Could Be About to Reap the Rewards of a Software Spending Boom
- Best Buy’s Turnaround Is Gaining Traction, But Wall Street Still Needs Proof
- AI Fears Hit Nebius Stock, But Has the Growth Thesis Changed?
Receive News & Ratings for Evotec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evotec and related companies with MarketBeat.com's FREE daily email newsletter.
